Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cefixime
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Aurum Institute | Nyanza Reproductive Health Society | Partners for Health and Development in Africa | National Institute of Allergy and Infectious Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable
Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM
Details : Cefixime is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Gonorrhea.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 21, 2024
Lead Product(s) : Cefixime
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Aurum Institute | Nyanza Reproductive Health Society | Partners for Health and Development in Africa | National Institute of Allergy and Infectious Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cefixime
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Pharma Metric Labs
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioequivalence Study of Cefixime Trihydrate Dry Syrup in Indonesia Healthy Volunteers
Details : Cefixime Trihydrate is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Substance-Related Disorders.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 29, 2021
Lead Product(s) : Cefixime
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Pharma Metric Labs
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cefixime
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I/ Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Cefixime is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Syphilis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 23, 2018
Lead Product(s) : Cefixime
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I/ Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cefixime
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Cefixime is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Bacterial Infections.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 06, 2017
Lead Product(s) : Cefixime
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable